Tuesday , May 11 2021

The Japan team transplant cells into the brain to treat Parkinson's



The man was stable after the surgery, which was performed last month, and will now be monitored for two years, the university added.

TOKYO, Japan – Japanese researchers said on Friday that they had transplanted cell cells into a patient's brain during the first phase of an innovative test to improve Parkinson's disease.

The research team at Kyoto University spray Miscellaneous Miscellaneous cells (iPS) – who have the potential to develop into any cell in the body – to the brain of a male patient in the middle of the half, the university said in a statement to # 39; the press.

The man was stable after the surgery, which was performed last month, and will now be monitored for two years, the university added.

The researchers injected 2.4 million iPS cells to the left side of the patient's brain, in a surgery that took about three hours.

If there are no problems in the next six months, they will implant another 2.4 million cells to the right.

IPS cells from healthy donors have been developed as cellular predecessors that produce dopamine, who are no longer present in people with Parkinson's.

The operation came after the university announced in July that they would carry out the trial with seven participants aged between 50 and 69.

The first is to involve the implantation of cell cells in the brain to improve Parkinson's.

"I appreciate the patients for taking part in the trial with courage and determination," said Professor of Kyoto University, Jun Takahashi, on Thursday, according to the NHK public broadcaster.

Parkinson's disease is a chronic, degenerative neurological disorder that affects the body's motor system, often causes shaking and other mobility difficulties.

Across the world, around 10 million people have the illness, according to the Parkinson's Disease Foundation.

Therapies currently available "improve symptoms without slowing down or preventing the increase in the disease," said the base.

The human trials come after an earlier trial involving monkeys.

Last year's researchers announced that wings with Parkinson's symptoms have recovered significant mobility after iPS was placed in their brains.

It was also confirmed that the iPS cells had not converted into tumors during the two years after the implant.

IPS cells are created by stimulating mature cells, already specializing, back into a young state – basically cloning without the need for embryo.

Cells can be transformed into different types of cells, and their use is a key sector of medical research.


Source link